| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.006 |